Six-minute walking test performance is associated with survival in cirrhotic patients

Table 1 Patients’ characteristics (n = 106), n (%)

Characteristic	n (%) or means ± SD
Gender M/F	59/47 (56/44)
Age (yr)	51 ± 13
BMI (kg/m2)	25.7 ± 4.7
PASP (mmHg)	25.4 ± 8.0
Cirrhosis etiology
Virus	36 (33.9)
Alcohol	32 (30.2)
NASH	8 (7.5)
Others	30 (28.4)
Child-Pugh class n	7.1 ± 1.8
A	23 (21.7)
B	70 (66)
C	13 (12.3)
MELD	11.1 ± 3.1
Previous history of liver related decompensation	76 (73.8)
Hypertension	19 (17.9)
Diabetes	26 (24.5)
Tobacco smoking	12 (11.4)
Beta-blocker use	32 (30.2)
Hepatic decompensation on the day of the test
Ascites	34 (32.1)
(Grade 1, 2, and 3)	(11.3, 17, 5)
Peripheral edema	13 (12.3)
Hepatic encephalopathy	13 (12.3)
(Grade 1, 2, 3, and 4)	(10.4, 1.9, 0, 0)
Hepatocellular carcinoma	5 (4.7)
Patient on the liver transplantation waiting list	35 (33)
Baseline laboratory1
Hemoglobin (mg/dL)	13.1 ± 1.9
Hematocrit (%)	39.3 ± 5.4
Albumin (g/dL)Bilirubin (mg/dL)INR	3.5 ± 0.62.0 ± 1.51.2 ± 0.2
Creatinine (mg/dL)	0.8 ± 0.3
Na (mmol/L)	137.8 ± 2.1
K (mmol/L)	4.1 ± 0.5
Mg (mg/dL)	1.8 ± 0.2
Ca (mmol/L)	1.2 ± 0.1

¹Continuous variables are shown as means ± SD.

Reference range values: Na (136-145); K (3.5-5.0); Mg (1.6-2.6) and Ca (1.15-1.29).

M: Male; F: Female; PASP: Pulmonary arterial systolic pressure.